Chemesis International Inc. Subsidiary, Natural Ventures PR, LLC, to Remain Operational During COVID-19 Pandemic
Chemesis International Inc. Subsidiary, Natural Ventures PR, LLC, to Remain Operational During
COVID-19 Pandemic
All Green Spirit Rx. & Caribbean Green Dispensaries will operate from 8am-6pm
March 16, 2020
Vancouver, BC – Chemesis International Inc. (CSE: CSI ) ( OTC: CADMF ) ( FRA: CWAA ) (the “Company” or
“Chemesis”), announces its Puerto Rico operations will remain operational during the COVID-19 pandemic with
adjusted hours.
As per Executive Or der No. 2020 -023 (“Order”), medical cannabis establishments can continue to grow,
manufacture, sell, dispatch or transport medicinal cannabis products to patients across Puerto Rico. To remain
compliant under the Order, all Green Spirit Rx. and Caribbean G reen dispensaries will have operating hours
from 8am to 6pm daily, which will remain in effect until March 30, 2020 or until further notice.
“Chemesis continues to operate under new guidance to ensure patients are able to obtain the ir medical
cannabis,” said CEO of Chemesis, Edgar Montero.
On Behalf of The Board of Directors
Edgar Montero
CEO and Director
About Chemesis International Inc.
Chemesis International Inc. is a vertically integrated U.S. Multi-State operator with International operations in Puerto
Rico and Colombia.
The Company focuses on prudent capital allocation to ensure it maintains a first mover advantage as it enters new
markets and i s committed to differentiate itself by deploying resources in markets with major opportunities. The
Company operates a portfolio of brands that cater to a wide community of cannabis consumers, with focus on quality
and consistency.
Chemesis has facilities in both Puerto Rico and California. The Company is positioned to win additional licenses in
highly competitive merit-based US states and will expand its footprint to ensure it maintains a first mover advantage.
Investor Relations:
1 (604) 398-3378
Forward-Looking Information: This news release contains "forward -looking information" within the meaning of applicable
securities laws relating to statements regarding the Company's business, products and future of the Company’s business, its
product offerings and plans for sales and marketing, including with respect to the Company’s expectations regarding its suppl y
and distribution arrangements, ability to realize benefits from its recent contractual arrangements, its plans to continue to
develop dispensaries in Puerto Rico, and its ability to obtain licenses in additional jurisdictions. Although the Company be lieves
that the expectations reflected in the forward -looking i nformation are reasonable, there can be no assurance that such
expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward -looking information. Such
forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments
to differ materially from those contemplated by these statements depending on, among other things, the risks that the
Company's products and plan will vary from those stated in this news release an d the Company may not be able to carry out its
business plans as expected, including, but not limited to, in relation to executing on and maintaining its supply and distrib ution
arrangements and recent contractual arrangements, in relation to developing dispensaries in Puerto Rico, and its ability to obtain
licenses in additional jurisdictions. Except as required by law, the Company expressly disclaims any obligation and does not intend
to update any forward-looking statements or forward-looking information in this news release. Although the Company believes
that the expectations reflected in the forward -looking information are reasonable, there can be no assurance that such
expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news
release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release